🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOrforglipron Phase 3 ATTAIN-1 topline — anyone have experience? Page 5

Orforglipron Phase 3 ATTAIN-1 topline — anyone have experience?

steve_okc Sat, Apr 26, 2025 at 11:16 AM 30 replies 1,800 viewsPage 5 of 6
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
May 3, 2025 at 12:53 PM#21
lisa_labSD said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

Coming at lisa_labSD’s question from a different direction. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

Last edited: May 3, 2025 at 5:53 PM
31 4Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 28 others
Reply Quote Save Share Report
jason_paloalto
Member
212
890
Nov 2024
Palo Alto, CA
May 5, 2025 at 7:33 AM#22

The figures, for anyone assembling their own picture. Worth stating the units and the reference range whenever you post a number here. A large fraction of the apparent disagreement in these threads is two people using different units and both being right.

Last edited: May 5, 2025 at 12:33 PM
32 5Dr.PathRoch, mona_PHX, andrew_nyc and 29 others
Reply Quote Save Share Report
paige_pharma
Member
289
1,234
Sep 2024
Omaha, NE
May 7, 2025 at 2:14 AM#23

One thing that is still open after lisa_labSD’s answer:

How would you tell the difference between that and the alternative explanation?

33 6adam_van, Dr.SurgeonPGH, rachel_ABQ and 30 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
amsterdam_pete
Senior Member
1,567
6,789
Feb 2024
Netherlands
May 8, 2025 at 8:56 PM#24
jason_paloalto said:
Worth stating the units and the reference range whenever you post a number here.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. I think the framing smuggles in the conclusion. Ask it the other way round and the obvious answer reverses, which usually means the question is doing the work.

I would rather be corrected than agreed with, if it comes to it.

Last edited: May 9, 2025 at 2:56 AM
34 7KetoKyle, CanadaChris, ZaraB_AL and 31 others
Reply Quote Save Share Report
GenomicsKate
Member
345
1,890
Oct 2024
Cambridge, MA
May 10, 2025 at 3:39 PM#25
jason_paloalto said:
Worth stating the units and the reference range whenever you post a number here.

No disagreement, though the timescale matters more than the mechanism here. Most of what looks like a difference in kind turns out to be a difference in how long somebody waited.

Last edited: May 10, 2025 at 8:39 PM
35 8claudia_zurich, nancy_portland, rick_sfbay and 32 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register